| scholarly article | Q13442814 |
| P2093 | author name string | William Langridge | |
| Nan-Sun Kim | |||
| Timothy Torrez | |||
| P2860 | cites work | Dendritic cell subsets in type 1 diabetes: friend or foe? | Q26866500 |
| Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010 | Q28254978 | ||
| In situ characterization of dendritic cells occurring in the islets of nonobese diabetic mice during the development of insulitis | Q30858273 | ||
| Cholera toxin - a foe & a friend. | Q34026162 | ||
| Autoantigens plus interleukin-10 suppress diabetes autoimmunity | Q34113929 | ||
| The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation | Q34116134 | ||
| Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association | Q34219439 | ||
| A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes | Q34452991 | ||
| Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. | Q34629092 | ||
| How tolerogenic dendritic cells induce regulatory T cells | Q34631825 | ||
| Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine. | Q35122841 | ||
| Antigen targets of type 1 diabetes autoimmunity | Q35852999 | ||
| Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway | Q35924786 | ||
| Current and future immunomodulation strategies to restore tolerance in autoimmune diseases | Q36506677 | ||
| Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. | Q36551840 | ||
| Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease | Q37088180 | ||
| Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant | Q37351448 | ||
| Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit | Q37657673 | ||
| The role of indoleamine 2,3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs. | Q37678976 | ||
| Clinical immunologic interventions for the treatment of type 1 diabetes | Q38036230 | ||
| Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides | Q38309722 | ||
| Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens | Q40382880 | ||
| Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta | Q44158248 | ||
| A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes | Q45889680 | ||
| IDO inhibits T-cell function through suppressing Vav1 expression and activation. | Q45930000 | ||
| Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model | Q46859808 | ||
| IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells | Q46941757 | ||
| Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease | Q47346480 | ||
| Mechanism of chimeric vaccine stimulation of indoleamine 2,3-dioxygenase biosynthesis in human dendritic cells is independent of TGF-β signaling | Q47868586 | ||
| Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. | Q53555159 | ||
| Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells. | Q53575346 | ||
| Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity | Q56907237 | ||
| Effects of cyclosporine A on T cell development and clonal deletion | Q68097628 | ||
| Insulin-dependent diabetes mellitus | Q71046915 | ||
| Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits | Q72169038 | ||
| Defective maturation and function of antigen-presenting cells in type 1 diabetes | Q72559435 | ||
| Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities | Q72813025 | ||
| Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit | Q73022255 | ||
| Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells | Q73117338 | ||
| Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes | Q73943062 | ||
| Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
| Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides | Q77408145 | ||
| Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice | Q78402068 | ||
| Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells | Q79859166 | ||
| Flt3-ligand treatment prevents diabetes in NOD mice | Q80384638 | ||
| B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis | Q83256564 | ||
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 32-42 | |
| P577 | publication date | 2019-03-19 | |
| P1433 | published in | Cellular Immunology | Q2597167 |
| P1476 | title | LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells | |
| P478 | volume | 338 |
| Q90479791 | IDO and Kynurenine Metabolites in Peripheral and CNS Disorders | cites work | P2860 |
Search more.